| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $64.55M | $49.15M | $43.61M | $67.06M | $47.49M |
| R&D | $42.63M | $31.70M | $24.99M | $16.81M | $21.09M |
| SG&A | $21.92M | $17.45M | $18.62M | $20.74M | $26.40M |
| Operating Income | -$64.55M | -$49.15M | -$43.61M | -$67.06M | -$47.49M |
| Interest Expense | – | – | – | – | $0.00 |
| Tax Expense | – | – | – | – | – |
| Net Income | -$57.44M | -$44.60M | -$40.42M | -$65.95M | -$47.25M |
| EPS (basic) | -1.3400 | -2.1700 | -3.5700 | -5.8600 | -4.2100 |
| EPS (diluted) | -1.3400 | -2.1700 | -3.5700 | -5.8600 | -4.2100 |
| Shares (diluted) | $42.84M | $20.59M | $11.33M | $11.26M | $11.23M |